Q4 2024 Holdings
Filed 2025-02-14 | 193 holdings | $5.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $364.8M | 593,184 | 7.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $275.1M | 7,868,700 | 5.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $248.4M | 1,820,000 | 4.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $242.4M | 464,377 | 4.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $203.8M | 2,440,240 | 3.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $196.3M | 487,434 | 3.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $191.9M | 4,386,900 | 3.7% |
| Abbott Labs(ABT) | COM | 002824100 | $191.0M | 1,688,660 | 3.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $190.7M | 2,135,295 | 3.7% |
| Stryker Corporation(SYK) | COM | 863667101 | $187.2M | 520,026 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $181.3M | 770,268 | 3.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $149.0M | 2,157,478 | 2.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $115.5M | 3,515,150 | 2.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $108.5M | 2,510,690 | 2.1% |
| Insulet Corp(PODD) | COM | 45784P101 | $84.0M | 321,917 | 1.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $83.3M | 1,042,948 | 1.6% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $81.3M | 1,097,848 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $81.3M | 1,045,044 | 1.6% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $80.8M | 159,713 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $77.6M | 3,071,615 | 1.5% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $76.6M | 337,548 | 1.5% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $76.2M | 2,040,853 | 1.5% |
| Moderna Inc(MRNA) | COM | 60770K107 | $66.6M | 1,600,877 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $56.5M | 238,053 | 1.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $50.6M | 4,094,458 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $45.8M | 2,389,600 | 0.9% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $41.0M | 524,414 | 0.8% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $39.0M | 694,056 | 0.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $38.2M | 1,428,929 | 0.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $37.6M | 1,518,121 | 0.7% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $37.3M | 462,894 | 0.7% |
| Resmed Inc(RMD) | COM | 761152107 | $36.8M | 160,793 | 0.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $35.6M | 1,205,464 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $35.1M | 45,465 | 0.7% |
| The Cigna Group(CI) | COM | 125523100 | $34.6M | 125,205 | 0.7% |
| Align Technology Inc(ALGN) | COM | 016255101 | $33.4M | 160,003 | 0.6% |
| Cooper COS Inc(COO) | COM | 216648501 | $32.8M | 357,130 | 0.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $32.3M | 9,929,963 | 0.6% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $31.8M | 76,935 | 0.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $31.7M | 60,962 | 0.6% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $31.0M | 293,621 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $30.4M | 7,377,292 | 0.6% |
| Globus MED Inc(GMED) | CL A | 379577208 | $30.0M | 362,979 | 0.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $29.4M | 1,374,412 | 0.6% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $28.2M | 782,456 | 0.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $27.5M | 119,922 | 0.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $27.5M | 148,478 | 0.5% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $26.8M | 127,575 | 0.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $26.5M | 5,157,290 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $26.4M | 568,955 | 0.5% |